Cancer-related fatigue and its impact on functioning

Ollie Minton, Ann Malone Berger, Andrea Barsevick, Fiona Cramp, Martine Goedendorp, Sandra A. Mitchell, Patrick C. Stone

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

This article presents the contrasting European and American perspectives on cancer-related fatigue (CRF) and its impact on functioning in cancer survivors. The content is presented in 3 sections: state of the art, intervention studies, and future areas of research, followed by a discussion. Gaps identified include a lack of understanding of the etiology, definition, and measurement of CRF. Models to guide the study of CRF, selection of biomarkers, and design of interventions are needed. There is overlap between Europe and the United States concerning the future directions for research and collaboration related to CRF. The authors suggest the need for international consensus regarding the defining features of CRF in cancer survivors to identify phenotypes, a harmonized measurement of CRF outcomes using instruments that have demonstrated measurement equivalence across languages and cultures, and interventions (including exercise, rehabilitation, and psychoeducational) that have been manualized to permit intervention fidelity across diverse contexts. Coordinated intercontinental efforts would increase understanding of the biological, psychological, and social mechanisms underlying CRF and assist in the design of future intervention studies as well as revisions to clinical guidelines.

Original languageEnglish (US)
Pages (from-to)2124-2130
Number of pages7
JournalCancer
Volume119
Issue numberSUPPL11
DOIs
StatePublished - Jun 1 2013

Fingerprint

Fatigue
Neoplasms
Exercise Therapy
Research
Consensus
Language
Biomarkers
Guidelines
Psychology
Phenotype

Keywords

  • cancer-related fatigue
  • interventions
  • neoplasms
  • survivors

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Minton, O., Berger, A. M., Barsevick, A., Cramp, F., Goedendorp, M., Mitchell, S. A., & Stone, P. C. (2013). Cancer-related fatigue and its impact on functioning. Cancer, 119(SUPPL11), 2124-2130. https://doi.org/10.1002/cncr.28058

Cancer-related fatigue and its impact on functioning. / Minton, Ollie; Berger, Ann Malone; Barsevick, Andrea; Cramp, Fiona; Goedendorp, Martine; Mitchell, Sandra A.; Stone, Patrick C.

In: Cancer, Vol. 119, No. SUPPL11, 01.06.2013, p. 2124-2130.

Research output: Contribution to journalArticle

Minton, O, Berger, AM, Barsevick, A, Cramp, F, Goedendorp, M, Mitchell, SA & Stone, PC 2013, 'Cancer-related fatigue and its impact on functioning', Cancer, vol. 119, no. SUPPL11, pp. 2124-2130. https://doi.org/10.1002/cncr.28058
Minton O, Berger AM, Barsevick A, Cramp F, Goedendorp M, Mitchell SA et al. Cancer-related fatigue and its impact on functioning. Cancer. 2013 Jun 1;119(SUPPL11):2124-2130. https://doi.org/10.1002/cncr.28058
Minton, Ollie ; Berger, Ann Malone ; Barsevick, Andrea ; Cramp, Fiona ; Goedendorp, Martine ; Mitchell, Sandra A. ; Stone, Patrick C. / Cancer-related fatigue and its impact on functioning. In: Cancer. 2013 ; Vol. 119, No. SUPPL11. pp. 2124-2130.
@article{a53144766d20412a95c38f04dcb98e27,
title = "Cancer-related fatigue and its impact on functioning",
abstract = "This article presents the contrasting European and American perspectives on cancer-related fatigue (CRF) and its impact on functioning in cancer survivors. The content is presented in 3 sections: state of the art, intervention studies, and future areas of research, followed by a discussion. Gaps identified include a lack of understanding of the etiology, definition, and measurement of CRF. Models to guide the study of CRF, selection of biomarkers, and design of interventions are needed. There is overlap between Europe and the United States concerning the future directions for research and collaboration related to CRF. The authors suggest the need for international consensus regarding the defining features of CRF in cancer survivors to identify phenotypes, a harmonized measurement of CRF outcomes using instruments that have demonstrated measurement equivalence across languages and cultures, and interventions (including exercise, rehabilitation, and psychoeducational) that have been manualized to permit intervention fidelity across diverse contexts. Coordinated intercontinental efforts would increase understanding of the biological, psychological, and social mechanisms underlying CRF and assist in the design of future intervention studies as well as revisions to clinical guidelines.",
keywords = "cancer-related fatigue, interventions, neoplasms, survivors",
author = "Ollie Minton and Berger, {Ann Malone} and Andrea Barsevick and Fiona Cramp and Martine Goedendorp and Mitchell, {Sandra A.} and Stone, {Patrick C.}",
year = "2013",
month = "6",
day = "1",
doi = "10.1002/cncr.28058",
language = "English (US)",
volume = "119",
pages = "2124--2130",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "SUPPL11",

}

TY - JOUR

T1 - Cancer-related fatigue and its impact on functioning

AU - Minton, Ollie

AU - Berger, Ann Malone

AU - Barsevick, Andrea

AU - Cramp, Fiona

AU - Goedendorp, Martine

AU - Mitchell, Sandra A.

AU - Stone, Patrick C.

PY - 2013/6/1

Y1 - 2013/6/1

N2 - This article presents the contrasting European and American perspectives on cancer-related fatigue (CRF) and its impact on functioning in cancer survivors. The content is presented in 3 sections: state of the art, intervention studies, and future areas of research, followed by a discussion. Gaps identified include a lack of understanding of the etiology, definition, and measurement of CRF. Models to guide the study of CRF, selection of biomarkers, and design of interventions are needed. There is overlap between Europe and the United States concerning the future directions for research and collaboration related to CRF. The authors suggest the need for international consensus regarding the defining features of CRF in cancer survivors to identify phenotypes, a harmonized measurement of CRF outcomes using instruments that have demonstrated measurement equivalence across languages and cultures, and interventions (including exercise, rehabilitation, and psychoeducational) that have been manualized to permit intervention fidelity across diverse contexts. Coordinated intercontinental efforts would increase understanding of the biological, psychological, and social mechanisms underlying CRF and assist in the design of future intervention studies as well as revisions to clinical guidelines.

AB - This article presents the contrasting European and American perspectives on cancer-related fatigue (CRF) and its impact on functioning in cancer survivors. The content is presented in 3 sections: state of the art, intervention studies, and future areas of research, followed by a discussion. Gaps identified include a lack of understanding of the etiology, definition, and measurement of CRF. Models to guide the study of CRF, selection of biomarkers, and design of interventions are needed. There is overlap between Europe and the United States concerning the future directions for research and collaboration related to CRF. The authors suggest the need for international consensus regarding the defining features of CRF in cancer survivors to identify phenotypes, a harmonized measurement of CRF outcomes using instruments that have demonstrated measurement equivalence across languages and cultures, and interventions (including exercise, rehabilitation, and psychoeducational) that have been manualized to permit intervention fidelity across diverse contexts. Coordinated intercontinental efforts would increase understanding of the biological, psychological, and social mechanisms underlying CRF and assist in the design of future intervention studies as well as revisions to clinical guidelines.

KW - cancer-related fatigue

KW - interventions

KW - neoplasms

KW - survivors

UR - http://www.scopus.com/inward/record.url?scp=84877991480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877991480&partnerID=8YFLogxK

U2 - 10.1002/cncr.28058

DO - 10.1002/cncr.28058

M3 - Article

C2 - 23695924

AN - SCOPUS:84877991480

VL - 119

SP - 2124

EP - 2130

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - SUPPL11

ER -